Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-02

FDA Approved: VIGABATRIN — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves Zydus Lifesciences Limited's original ANDA for Vigabatrin, allowing a generic version of the anti-epileptic drug. The approval covers the same indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN (VIGABATRIN)